New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
Roxana Popescu,Mihaela Violeta Ghica,Cristina-Elena Dinu-Pîrvu,Valentina Anuța,Dumitru Lupuliasa,Lăcrămioara Popa
DOI: https://doi.org/10.3390/ijms21145016
IF: 5.6
2020-07-16
International Journal of Molecular Sciences
Abstract:In an attempt to develop drug delivery systems that bypass the blood–brain barrier (BBB) and prevent liver and intestinal degradation, it was concluded that nasal medication meets these criteria and can be used for drugs that have these drawbacks. The aim of this review is to present the influence of the properties of chitosan and its derivatives (mucoadhesion, permeability enhancement, surface tension, and zeta potential) on the development of suitable nasal drug delivery systems and on the nasal bioavailability of various active pharmaceutical ingredients. Interactions between chitosan and proteins, lipids, antigens, and other molecules lead to complexes that have their own applications or to changing characteristics of the substances involved in the bond (conformational changes, increased stability or solubility, etc.). Chitosan and its derivatives have their own actions (antibacterial, antifungal, immunostimulant, antioxidant, etc.) and can be used as such or in combination with other molecules from the same class to achieve a synergistic effect. The applicability of the properties is set out in the second part of the paper, where nasal formulations based on chitosan are described (vaccines, hydrogels, nanoparticles, nanostructured lipid carriers (NLC), powders, emulsions, etc.).
biochemistry & molecular biology,chemistry, multidisciplinary